HemOnc.org - A Hematology Oncology Wiki - Recent changes [en]

← Older revision Revision as of 18:58, 1 May 2026 (One intermediate revision by the same user not shown)Line 1: Line 1: {{Teratogenic}} {{Special precautions}} == General information and mechanism of action ==== General information and mechanism of action == From the NCI Thesaurus: "An orally available hetero-bifunctional molecule and selective estrogen...

Tamoxifen monotherapy

← Older revision Revision as of 18:54, 1 May 2026 (One intermediate revision by the same user not shown)Line 2,949: Line 2,949: |<time datetime="2023-03-03">March 3, 2023</time> to <time datetime="2024-10-30">October 30, 2024</time>|<time datetime="2023-03-03">March 3, 2023</time> to <time date...

V

← Older revision Revision as of 18:43, 1 May 2026 (One intermediate revision by the same user not shown)Line 552: Line 552: *[[Vemurafenib (Zelboraf)]]*[[Vemurafenib (Zelboraf)]] *[[Venetoclax (Venclexta)]]*[[Venetoclax (Venclexta)]] *[[Vepdegestrant (Veppanu)]] <span style="color:#cc0000;">'''FDA approved <time datetime="2026-05-01">May 1,...

EMA indications for colorectal cancer (CRC)

← Older revision Revision as of 14:17, 1 May 2026 (3 intermediate revisions by the same user not shown)Line 27: Line 27: == Regulatory indications ==== Regulatory indications == === History of changes in EMA indication ====== History of changes in EMA indication === ==== EMA indications for colorectal cancer (C...